Rick has more than 35 years of management experience in medtech and pharmaceuticals with a concentration in the cardiovascular space. He has led the company foundation of seven private-venture backed healthcare companies and the restructuring and redirection of two others.
He is currently the President and CEO of Cyrano Therapeutics, serves as the Chairman of UltraSight, Vice Chairman of The Mullings Group (TMG), a member of the Board of Directors for Approxima, Corflow and the Medical Device Innovation Consortium (MDIC) and a member of the External Advisory Committee for the Cleveland Clinic.
